🇺🇸 FDA
Patent

US 8916565

Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels

granted A61KA61K31/499A61K31/506

Quick answer

US patent 8916565 (Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61K, A61K31/499, A61K31/506, A61P, A61P1/00